Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 38, 2021 - Issue 6
1,150
Views
0
CrossRef citations to date
0
Altmetric
Brief Reports

The day-night pattern of colonic contractility is not impaired in type 1 diabetes and distal symmetric polyneuropathy

ORCID Icon, ORCID Icon, , , , , ORCID Icon, ORCID Icon & show all
Pages 801-806 | Received 10 Dec 2020, Accepted 22 Jan 2021, Published online: 11 Mar 2021
 

ABSTRACT

Colonic contractility normally shows circadian variability regulated by sleep and especially food intake. However, individuals with type 1 diabetes have a reduced or even absent gastrocolic response to a meal, indicating that colonic contractility may be affected by the disease. We hypothesized that individuals with type 1 diabetes and distal symmetric polyneuropathy (DSPN) have decreased motility (expressed as the motility index) and contractility of the colon and a reduced increase in motility index from night to morning compared to healthy controls and individuals with type 1 diabetes without DSPN. Cohorts of 35 individuals with type 1 diabetes and DSPN, 40 individuals with type 1 diabetes without DSPN, and 28 healthy controls were included in this post-hoc, cross-sectional analysis. We investigated, using a wireless motility capsule that measures pH, temperature, and pressure throughout the gastrointestinal tract, whether individuals with type 1 diabetes with and without DSPN, compared to healthy controls, exhibit altered colonic contractility in the evening, night, and morning. Max amplitude, mean peak amplitude, mean contraction, and motility index of the colon were calculated at the afore-designated times. Motility index of the colon tended to be higher in individuals with type 1 diabetes and DSPN compared to controls in the evening (P = .064), but the effect size was small (1.74%). There was no difference in motility index between the groups in the morning or evening. Furthermore, there was no difference in max amplitude, mean peak amplitude, or mean contraction between groups in the morning, evening, and night. As expected, overall contractility increased from night to morning in all groups, but there was no difference between groups in the increase in contractility from night to morning. Colonic contractility generally peaked in the morning, decreased in the evening, and was almost absent at night. Type 1 diabetes and/or DSPN did not impair contractility of the colon at any time point. Contractility and motility increased from morning to night unaffected by type 1 diabetes and/or DSPN.

Acknowledgements

Parts of this study were presented in abstract form at the Biennial Meeting of the European Society of Neurogastroenterology and Motility, 5th to 7th September 2019, Lisbon, Portugal and the 10th Annual Center for Circadian Biology Meeting, 4th to 6th March, San Diego, USA.

MMJ wrote the manuscript and researched data. ALW researched data, contributed to discussion and reviewed/edited the manuscript. SLJ, PSS, IMNW and VSZ researched data and reviewed/edited the manuscript. KF, JSQ and CB contributed to discussion and reviewed/edited the manuscript. All authors read and approved the final version of the manuscript and declare no conflicts of interest.

CB conceptualized the design and is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The DANMARK study was funded by grants from Knowledge for the World Talent Programme, Aalborg University and Karen Elise Jensen’s Foundation. The TODINELI study was funded by grants from Novo Nordisk Scandinavia; Empowering Industry and Research (EIR); The North Denmark Region and Karen Elise Jensen’s Foundation. The PRESET study was funded by a grant from The Novo Nordisk Foundation [grant number: NNF17OC0027822].